1. Academic Validation
  2. Divergent fates of antigen-specific CD8+ T cell clones in mice with acute leukemia

Divergent fates of antigen-specific CD8+ T cell clones in mice with acute leukemia

  • Cell Rep. 2021 Nov 9;37(6):109991. doi: 10.1016/j.celrep.2021.109991.
Xiufen Chen 1 Brendan W MacNabb 2 Blake Flood 2 Bruce R Blazar 3 Justin Kline 4
Affiliations

Affiliations

  • 1 Department of Medicine, University of Chicago, Chicago, IL, USA.
  • 2 Committee on Immunology, University of Chicago, Chicago, IL, USA.
  • 3 Department of Pediatrics, Division of Blood and Marrow Transplantation, University of Minnesota, Minneapolis, MN, USA.
  • 4 Department of Medicine, University of Chicago, Chicago, IL, USA; Committee on Immunology, University of Chicago, Chicago, IL, USA; University of Chicago Comprehensive Cancer Center, Chicago, IL, USA. Electronic address: jkline@medicine.bsd.uchicago.edu.
Abstract

The existence of a dysfunctional CD8+ T cell state in Cancer is well established. However, the degree to which CD8+ T cell fates are influenced by the context in which they encounter cognate tumor antigen is less clear. We previously demonstrated that CD8+ T cells reactive to a model leukemia antigen were deleted by antigen cross-presenting type 1 conventional dendritic cells (cDC1s). Here, through a study of T cell receptor (TCR) transgenic CD8+ T cells (TCRTg101) reactive to a native C1498 leukemia cell antigen, we uncover a different mode of T cell tolerance in which TCRTg101 undergo progressive expansion and differentiation into an exhausted state. Antigen encounter by TCRTg101 requires leukemia cell major histocompatibility complex (MHC)-I expression and is independent of DCs, implying that leukemia cells directly mediate the exhausted TCRTg101 phenotype. Collectively, our data reveal that leukemia antigens are presented to CD8+ T cells via discrete pathways, leading to distinct tolerant states.

Figures
Products